Khadijeh Jamialahmadi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Diabetic Retinopathy

Top Venues

The Journal of pharmacy and pharmacology

Molecular biology reports

Phytotherapy research : PTR

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Asefeh Dahmardeh Ghalehno, Hakimeh Abdi, Arad Boustan, Khadijeh Jamialahmadi, Fatemeh Mosaffa
Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Yasaman Abolhassani, Sara Mirzaei, Masoud Nejabat, Seyedehsaba Talebian, Hamid Gholamhosseinian, Mehrdad Iranshahi, Mohammad Reza Keramati, Khadijeh Jamialahmadi
7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells. Molecular biology reports (2023)
Fatemeh Zahedipour, Parvin Zamani, Mohammad Mashreghi, Mojgan Astaneh, Mojtaba Sankian, Atefeh Amiri, Khadijeh Jamialahmadi, Mahmoud Reza Jaafari
Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma. Cancer nanotechnology 14 (1) (2023)
Fatemeh Valinezhad Sani, Abbasali Palizban, Fatemeh Mosaffa, Khadijeh Jamialahmadi
Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells. The Journal of pharmacy and pharmacology 73 (7) (2021)
Khadijeh Jamialahmadi, Fatemeh Zahedipour, Gholamreza Karimi
The role of microRNAs on doxorubicin drug resistance in breast cancer. The Journal of pharmacy and pharmacology 73 (8) (2021)
Zohre Senobari, Gholamreza Karimi, Khadijeh Jamialahmadi
Ellagitannins, promising pharmacological agents for the treatment of cancer stem cells. Phytotherapy research : PTR (2021)
Rosa Jahangiri, Fatemeh Mosaffa, Amirnader EmamiRazavi, Masoumeh Gharib, Khadijeh Jamialahmadi
Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients. Pathology oncology research : POR 26 (3) (2019)
Rosa Jahangiri, Fatemeh Mosaffa, Amirnader Emami Razavi, Ladan Teimoori-Toolabi, Khadijeh Jamialahmadi
Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors. Journal of cellular physiology 233 (9) (2018)